MAHWAH, N.J., March 23, 2005 (PRIMEZONE) -- Nobel Biocare (Other OTC:NBCHF), the world leader in innovative esthetic dental solutions, cordially invites you to join the grand opening celebration of the New Nobel Biocare Training Institute & Procera(R) Manufacturing Facility.
Friday, 1 April 2005
at 800 Corporate Drive in Mahwah, NJ, 07430
Open House from 8.30 am - 5pm
Group Tours: 9am, 11am, 1:30 p.m., 3 p.m.
Ribbon Cutting: 1 p.m.
Nobel Biocare's new state-of-the-art manufacturing facility features the unique Procera(R) system where, based upon the latest scanning, CAD/CAM and production technology, ceramic dental crowns and bridges are fabricated with precision accuracy into esthetic and functional dental restorations. Each unit is custom-made and produced individually for a patient somewhere in the Americas. This new industrial technique is replacing a hundred year old handicraft procedure.
The new Training Institute features state-of-the-art facilities and interactive technology to provide high-end, comprehensive ceramic and surgical/restorative educational programs for dentists and dental technicians. The laboratory training area accommodates up to 40 lab technicians, and the didactic center accommodates up to 120 clinicians.
RSVP by 29 March 2005 to (800) 579-6515
Nobel Biocare is a medical devices group and the world leader in innovative esthetic dental solutions with its brands Branemark System(R), Replace(R) Select, NobelPerfect(TM), NobelDirect(TM) (dental implants) and Procera(R) (individualized dental prosthetics).Nobel Biocare is a one-stop shop for restorative esthetic dentistry, offering a wide range of innovative Crown & Bridge & Implant products, as well as training & education and clinically documented treatment concepts. Nobel Biocare has around 1,430 employees and in 2004 revenue totaled EUR 388 million (USD 482 million). The company is domiciled in Zurich, Switzerland with headquarters in Zurich and in Gothenburg, Sweden while production takes place at four production sites in Sweden and the U.S. Nobel Biocare has its own sales organizations in 29 countries. The shares of the parent company Nobel Biocare Holding AG are listed on the SWX Swiss Exchange and on the Stockholm Stock Exchange, Sweden.Celebrating 40 years of scientific heritage. In 1965, the first patient ever was treated by the original scientific dental implant system, the Branemark System(R). This event marks the breakthrough in modern dental implant therapy. Since then, millions of people have been helped to improved function, appearance and quality of life. The original fixtures in the first patient treated 40 years ago are still in place, providing firm bridge support. The Branemark System(R) has been scientifically documented in 1,500 articles.
Procera(R) is a high-tech process for the industrial production of individually designed crowns, bridges, laminates and abutments. The orders are received online around the clock. The received files contain digital information about the individual patient's tooth. The mostly robotized production process starts immediately and after a few hours the custom-made product is sent via courier to the dental lab that ordered it. Every piece is unique and individually produced for a patient. Until today, Nobel Biocare has produced more than 5 million Procera units worldwide.
Nobel Biocare Holding AG, Postfach, 8058 Zurich-Flughafen, Switzerland.www.nobelbiocare.com